Goldman Sachs’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240K | Sell |
76,334
-30,799
| -29% | -$97K | ﹤0.01% | 4637 |
|
|
2025
Q1 | $336K | Sell |
107,133
-45,901
| -30% | -$144K | ﹤0.01% | 4458 |
|
|
2024
Q4 | $664K | Buy |
153,034
+59,053
| +63% | +$256K | ﹤0.01% | 4142 |
|
|
2024
Q3 | $251K | Sell |
93,981
-58,881
| -39% | -$157K | ﹤0.01% | 4414 |
|
|
2024
Q2 | $339K | Sell |
152,862
-133,012
| -47% | -$295K | ﹤0.01% | 4143 |
|
|
2024
Q1 | $1.53M | Buy |
+285,874
| New | +$1.53M | ﹤0.01% | 3358 |
|
|
2022
Q4 | – | Sell |
-14,349
| Closed | -$22K | – | 5179 |
|
|
2022
Q3 | $22K | Sell |
14,349
-27,503
| -66% | -$42.2K | ﹤0.01% | 5148 |
|
|
2022
Q2 | $92K | Sell |
41,852
-305,195
| -88% | -$671K | ﹤0.01% | 5138 |
|
|
2022
Q1 | $861K | Sell |
347,047
-23,081
| -6% | -$57.3K | ﹤0.01% | 4217 |
|
|
2021
Q4 | $2.22M | Buy |
370,128
+12,456
| +3% | +$74.8K | ﹤0.01% | 3432 |
|
|
2021
Q3 | $2.38M | Buy |
357,672
+275,151
| +333% | +$1.83M | ﹤0.01% | 3339 |
|
|
2021
Q2 | $549K | Buy |
82,521
+19,144
| +30% | +$127K | ﹤0.01% | 4376 |
|
|
2021
Q1 | $587K | Buy |
+63,377
| New | +$587K | ﹤0.01% | 4247 |
|
|
2018
Q2 | – | Sell |
-209
| Closed | -$5K | – | 4187 |
|
|
2018
Q1 | $5K | Sell |
209
-4
| -2% | -$96 | ﹤0.01% | 4183 |
|
|
2017
Q4 | $5K | Buy |
213
+6
| +3% | +$141 | ﹤0.01% | 4135 |
|
|
2017
Q3 | $11K | Sell |
207
-3,657
| -95% | -$194K | ﹤0.01% | 4228 |
|
|
2017
Q2 | $351K | Buy |
3,864
+3,536
| +1,078% | +$321K | ﹤0.01% | 3716 |
|
|
2017
Q1 | $27K | Sell |
328
-313
| -49% | -$25.8K | ﹤0.01% | 4293 |
|
|
2016
Q4 | $97K | Sell |
641
-1,015
| -61% | -$154K | ﹤0.01% | 4109 |
|
|
2016
Q3 | $535K | Sell |
1,656
-1,031
| -38% | -$333K | ﹤0.01% | 3399 |
|
|
2016
Q2 | $876K | Sell |
2,687
-278
| -9% | -$90.6K | ﹤0.01% | 3023 |
|
|
2016
Q1 | $993K | Buy |
2,965
+767
| +35% | +$257K | ﹤0.01% | 2872 |
|
|
2015
Q4 | $855K | Buy |
2,198
+159
| +8% | +$61.8K | ﹤0.01% | 2979 |
|
|
2015
Q3 | $835K | Sell |
2,039
-2,256
| -53% | -$924K | ﹤0.01% | 3014 |
|
|
2015
Q2 | $3.14M | Buy |
+4,295
| New | +$3.14M | ﹤0.01% | 2330 |
|